Chiaki Kuriyama

701 total citations
13 papers, 464 citations indexed

About

Chiaki Kuriyama is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Chiaki Kuriyama has authored 13 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in Chiaki Kuriyama's work include Diabetes Treatment and Management (10 papers), Pancreatic function and diabetes (8 papers) and Metabolism, Diabetes, and Cancer (6 papers). Chiaki Kuriyama is often cited by papers focused on Diabetes Treatment and Management (10 papers), Pancreatic function and diabetes (8 papers) and Metabolism, Diabetes, and Cancer (6 papers). Chiaki Kuriyama collaborates with scholars based in Japan, United States and Norway. Chiaki Kuriyama's co-authors include Kiichiro Ueta, Yasuaki Matsushita, Kenji Arakawa, Keiko Nakayama, Tonya Martin, Keith T. Demarest, Barbara R. Conway, Kirk Ways, David Polidori and Fuyong Du and has published in prestigious journals such as PLoS ONE, Journal of Pharmacology and Experimental Therapeutics and Bioorganic & Medicinal Chemistry.

In The Last Decade

Chiaki Kuriyama

11 papers receiving 452 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chiaki Kuriyama Japan 9 343 267 178 69 37 13 464
Yasuaki Matsushita Japan 10 316 0.9× 241 0.9× 173 1.0× 95 1.4× 35 0.9× 13 459
Yukiko Takemura Japan 5 260 0.8× 176 0.7× 179 1.0× 42 0.6× 48 1.3× 7 431
Fuyong Du United States 11 258 0.8× 194 0.7× 238 1.3× 147 2.1× 37 1.0× 17 548
Hitoshi Hagita United States 9 230 0.7× 135 0.5× 191 1.1× 93 1.3× 43 1.2× 9 408
Jessica D. Dietz United States 8 327 1.0× 164 0.6× 146 0.8× 55 0.8× 34 0.9× 8 496
Hironobu Mitani Japan 16 123 0.4× 206 0.8× 118 0.7× 24 0.3× 83 2.2× 27 489
Sharon Zhao United States 5 287 0.8× 114 0.4× 100 0.6× 26 0.4× 12 0.3× 9 437
Anne Turnage United States 4 287 0.8× 200 0.7× 143 0.8× 8 0.1× 30 0.8× 6 342
Dennis Ruff United States 10 163 0.5× 102 0.4× 111 0.6× 14 0.2× 17 0.5× 19 366
Flavia Impronta Italy 8 219 0.6× 136 0.5× 137 0.8× 6 0.1× 18 0.5× 9 317

Countries citing papers authored by Chiaki Kuriyama

Since Specialization
Citations

This map shows the geographic impact of Chiaki Kuriyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiaki Kuriyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiaki Kuriyama more than expected).

Fields of papers citing papers by Chiaki Kuriyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiaki Kuriyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiaki Kuriyama. The network helps show where Chiaki Kuriyama may publish in the future.

Co-authorship network of co-authors of Chiaki Kuriyama

This figure shows the co-authorship network connecting the top 25 collaborators of Chiaki Kuriyama. A scholar is included among the top collaborators of Chiaki Kuriyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiaki Kuriyama. Chiaki Kuriyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
2.
Kato, Masakazu, et al.. (2025). Relationship between maternal body composition changes and heavy for date infants in pregnant women with diabetes. Journal of Diabetes Investigation. 16(10). 1910–1918.
3.
Kuriyama, Chiaki, Keiko Nakayama, Yasuaki Matsushita, et al.. (2016). Changes in glucose-induced plasma active glucagon-like peptide-1 levels by co-administration of sodium–glucose cotransporter inhibitors with dipeptidyl peptidase-4 inhibitors in rodents. Journal of Pharmacological Sciences. 132(4). 255–261. 6 indexed citations
4.
Kuriyama, Chiaki, Kiichiro Ueta, & Kenji Arakawa. (2015). Pharmacological and clinical profile of a novel SGLT2 inhibitor canagliflozin hydrate (CANAGLU<sup>®</sup>). Folia Pharmacologica Japonica. 146(6). 332–341. 4 indexed citations
5.
Nakayama, Keiko, Chiaki Kuriyama, Yasuaki Matsushita, et al.. (2015). Intestinal Sodium Glucose Cotransporter 1 Inhibition Enhances Glucagon-Like Peptide-1 Secretion in Normal and Diabetic Rodents. Journal of Pharmacology and Experimental Therapeutics. 354(3). 279–289. 54 indexed citations
6.
Watanabe, Yoshinori, Keiko Nakayama, Yasushi Horai, et al.. (2015). Beneficial Effects of Canagliflozin in Combination with Pioglitazone on Insulin Sensitivity in Rodent Models of Obese Type 2 Diabetes. PLoS ONE. 10(1). e0116851–e0116851. 36 indexed citations
7.
Kuriyama, Chiaki, Keiko Nakayama, Yasuaki Matsushita, et al.. (2015). The effect of combined treatment with canagliflozin and teneligliptin on glucose intolerance in Zucker diabetic fatty rats. Journal of Pharmacological Sciences. 127(4). 456–461. 23 indexed citations
8.
Kuriyama, Chiaki, Jun Xu, Jenson Qi, et al.. (2014). Analysis of the Effect of Canagliflozin on Renal Glucose Reabsorption and Progression of Hyperglycemia in Zucker Diabetic Fatty Rats. Journal of Pharmacology and Experimental Therapeutics. 351(2). 423–431. 34 indexed citations
9.
Koga, Yuichi, Shigeki Sakamaki, Mitsuya Hongu, et al.. (2013). C-Glucosides with heteroaryl thiophene as novel sodium-dependent glucose cotransporter 2 inhibitors. Bioorganic & Medicinal Chemistry. 21(17). 5561–5572. 26 indexed citations
10.
Yamamoto, Yasuo, Eiji Kawanishi, Yuichi Koga, et al.. (2013). N-glucosides as human sodium-dependent glucose cotransporter 2 (hSGLT2) inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(20). 5641–5645. 21 indexed citations
11.
Nomura, Sumihiro, Yasuo Yamamoto, Yosuke Matsumura, et al.. (2013). Novel Indole-N-glucoside, TA-1887 As a Sodium Glucose Cotransporter 2 Inhibitor for Treatment of Type 2 Diabetes. ACS Medicinal Chemistry Letters. 5(1). 51–55. 43 indexed citations
12.
Sakamaki, Shigeki, Eiji Kawanishi, Yuichi Koga, et al.. (2013). Synthesis and Biological Evaluation of Thiophene-<i>C</i>-glucosides as Sodium-Dependent Glucose Cotransporter 2 Inhibitors. Chemical and Pharmaceutical Bulletin. 61(10). 1037–1043. 17 indexed citations
13.
Liang, Yin, Kenji Arakawa, Kiichiro Ueta, et al.. (2012). Effect of Canagliflozin on Renal Threshold for Glucose, Glycemia, and Body Weight in Normal and Diabetic Animal Models. PLoS ONE. 7(2). e30555–e30555. 200 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026